| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |